A multicenter, single blind Phase I/IIa study of IFNalpha Kinoid in dermatomyositis.

Trial Profile

A multicenter, single blind Phase I/IIa study of IFNalpha Kinoid in dermatomyositis.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 31 Oct 2017

At a glance

  • Drugs Interferon alpha kinoid (Primary)
  • Indications Dermatomyositis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 31 Oct 2017 Status changed from planning to recruiting.
    • 31 Oct 2017 New trial record
    • 27 Oct 2017 According to a Neovacs media release, the company obtained U.S. FDA's acceptance of IND to expand this study into US. The study currently recruiting in European countries.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top